Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis
- DOI
- 10.3390/antibiotics13111048
- Published
- 2024-11-05
- Container
- Antibiotics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/antibiotics13111048,
title = {Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis},
author = {Carlos Risco-Risco and César Henriquez-Camacho and Marta Herrera-Rueda and José Barberán and David Andaluz-Ojeda},
year = {2024},
journal = {Antibiotics},
doi = {10.3390/antibiotics13111048},
url = {https://doi.org/10.3390/antibiotics13111048}
}RIS
TY - JOUR TI - Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis AU - Carlos Risco-Risco AU - César Henriquez-Camacho AU - Marta Herrera-Rueda AU - José Barberán AU - David Andaluz-Ojeda PY - 2024 JO - Antibiotics DO - 10.3390/antibiotics13111048 UR - https://doi.org/10.3390/antibiotics13111048 ER -
APA
Risco-Risco, C., Henriquez-Camacho, C., Herrera-Rueda, M., Barberán, J., & Andaluz-Ojeda, D. (2024). Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis. Antibiotics. https://doi.org/10.3390/antibiotics13111048
Source records
- crossref · retrieved 2026-09-25T13:16:11.740Z